BHVN Q1 2020 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena

BHVNBiohaven Ltd.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$727,00063.2% margin

Operating Income

-$151M-13114.2% margin

Net Income

-$173M-15024.9% margin

EPS (Diluted)

$-3.07

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$151M

Free Cash Flow

-$152M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$533M

Total Liabilities

$411M

Stockholders' Equity

$122M

Cash & Equivalents

$428M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$727,000	$0	—
Operating Income	-$151M	-$54M	-177.1%
Net Income	-$173M	-$62M	-177.6%